Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · Real-Time Price · USD
29.96
-1.48 (-4.71%)
At close: Nov 20, 2026, 4:00 PM EST
30.20
+0.24 (0.80%)
After-hours: Nov 20, 2026, 5:33 PM EST
Viridian Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Buy Initiates $47 | Buy | Initiates | $47 | +56.88% | Nov 19, 2026 |
| Wells Fargo | Wells Fargo | Buy Reiterates $34 → $39 | Buy | Reiterates | $34 → $39 | +30.17% | Nov 10, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $40 | Buy | Maintains | $40 | +33.51% | Nov 9, 2026 |
Unknown Analyst Leerink Partners No rating | Leerink Partners | Buy Reiterates $50 → $54 | Buy | Reiterates | $50 → $54 | +80.24% | Nov 5, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $26 → $33 | Buy | Maintains | $26 → $33 | +10.15% | Nov 5, 2026 |
| RBC Capital | RBC Capital | Buy Reiterates $38 → $41 | Buy | Reiterates | $38 → $41 | +36.85% | Nov 5, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $40 → $53 | Buy | Maintains | $40 → $53 | +76.90% | Nov 5, 2026 |
| Wedbush | Wedbush | Buy Maintains $41 → $42 | Buy | Maintains | $41 → $42 | +40.19% | Nov 4, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.